Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Yemil Atisha-Fregoso, Susan Malkiel, Kristina M. Harris, Margie Byron, Linna Ding, Sai Kanaparthi, William T. Barry, Wendy Gao, Kristin Ryker, Patti Tosta, Anca D. Askanase, Susan A. Boackle, W. Winn Chatham, Diane L. Kamen, David R. Karp, Kyriakos A. Kirou, S. Sam Lim, Bradley Marder, Maureen McMahon, Samir V. ParikhWilliam F. Pendergraft, Amber S. Podoll, Amit Saxena, David Wofsy, Betty Diamond, Dawn E. Smilek, Cynthia Aranow, Maria Dall’Era

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis'. Together they form a unique fingerprint.

Medicine & Life Sciences